Literature DB >> 3803456

Differential growth properties of metastatic large-cell lymphoma cells in target organ-conditioned medium.

G L Nicolson.   

Abstract

Metastatic variant sublines of the murine RAW117-P large cell lymphoma have been sequentially selected in vivo for enhanced liver (RAW117-H10) or lung (RAW117-L17) colonization. Such cell sublines were tested for their survival and growth in vitro in medium conditioned by soluble factors released from mouse kidney, brain, liver, or lung tissues. Liver-colonizing H10 and L17 sublines were growth-stimulated by target liver tissue-derived factors at concentrations that inhibited the growth of the parental cells. Lung-colonizing L17 as well as liver-colonizing H10 cells were stimulated by lung tissue factors at concentrations that growth-inhibited the parental cells. In contrast, there was no significant growth stimulation by factors from kidney or brain tissues. In general, the metastatic patterns of RAW117 cells correlated with their abilities to be stimulated by medium from target organ tissues, but other factors, such as organ-specific adhesion mechanisms [10-12], must also be involved in the specificity of blood-borne metastatic organ colonization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3803456     DOI: 10.1016/0014-4827(87)90031-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Partial purification of a liver-derived tumor cell growth inhibitor that differentially inhibits poorly-liver metastasizing cell lines: identification as an active subunit of arginase.

Authors:  P G Cavanaugh; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors.

Authors:  G L Nicolson; S E Custead; K M Dulski; L Milas
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

3.  Mechanism of liver-specific metastatic tumor spread in a murine tumor model.

Authors:  G Edel
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  The influence of the microenvironment of liver-specific tumor cell colonization in a murine tumor model.

Authors:  G Edel
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  The role of the spleen in the organ-specific metastasis of murine BW 5147 T lymphomas.

Authors:  C Schmidt; H Verschueren; D Toussaint-Demylle; T van den Berg; G Kraal; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

6.  Differential organ tissue adhesion, invasion, and growth properties of metastatic rat mammary adenocarcinoma cells.

Authors:  G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

7.  Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-gamma modulates the metastatic potential of murine RAW117 large-cell lymphoma cells.

Authors:  R A LaBiche; R J Tressler; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

8.  Patterning of B16 melanoma metastasis and colonization generally relates to tumor cell growth-stimulating or growth-inhibiting effects of organs and tissues.

Authors:  E F Valle; A D Zalka; L Groszek; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

Review 9.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

Review 10.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.